Cefadroxil

Product NDC: 68180-181
Requested package NDC: 68180-181-01
11-digit product format: 681800181
Labeler code: 68180
Product ID: 68180-181_3818bd15-cf3a-4b07-bef5-57169a33a170
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefadroxil
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Lupin Pharmaceuticals, Inc.
Application: ANDA065396
Marketing category: ANDA
Marketing start: 2008-04-23
Substance: CEFADROXIL
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68180-181	68180-181-01	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065396-001	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21
A065396-002	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065396-001	AB
A065396-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065396-001	CEFADROXIL	EQ 250MG BASE/5ML	FOR SUSPENSION / ORAL	AB		2008-02-21	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065396-002	CEFADROXIL	EQ 500MG BASE/5ML	FOR SUSPENSION / ORAL	AB	RS	2008-02-21	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065396-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065396-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065396-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065396-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065396-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065396-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065396-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065396-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065396-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065396-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065396-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065396-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065396-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065396-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065396-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065396-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065396-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065396-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065396-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065396-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065396-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065396-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065396-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065396-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065396-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065396-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065396-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065396-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065396-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065396-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065396-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065396-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065396-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065396-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065396-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065396-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065396-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065396-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065396-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065396-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefadroxil
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFADROXIL	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
280111G160	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
105171	Internal RxNorm lookup
309048	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
27009a05-4d2b-4618-be76-39f348240eda	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
560bed03-0257-a1db-0638-2c46fc35054c	Product name	2	20170824
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
34f1b9ee-0673-df8c-ddae-36eaf4c48382	Product name	1	20140508
3793572a-4958-68b2-f923-8cf695ec1cc1	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68180-181-01	Cefadroxil	50 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	50		9
68180-181-02	Cefadroxil	100 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	100		9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68180-181-02	ML - Milliliter	68180-181	07ff0cd4-7acb-4eab-b787-537672cf4353	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
CEFADROXIL ANHYDROUS	ACTIVE MOIETY	Q525PA8JJB	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
PINEAPPLE	INACTIVE INGREDIENT	2A88ZO081O	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-181	CEFADROXIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.]	8	Current NDC, Legacy NDC, 2 package rows	20250130_27009a05-4d2b-4618-be76-39f348240eda.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefadroxil	CEFADROXIL	Lupin Pharmaceuticals, Inc.	27009a05-4d2b-4618-be76-39f348240eda	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065396 application number: ANDA065396 ndc (package): 68180-181-01 ndc (product): 68180-181 ndc11 (package): 68180018101

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
280111G160	CEFADROXIL	66592-87-8	CEFADROXIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309048	cefadroxil 250 MG in 5 mL Oral Suspension	PSN	27009a05-4d2b-4618-be76-39f348240eda	9
105171	cefadroxil 500 MG in 5 mL Oral Suspension	PSN	27009a05-4d2b-4618-be76-39f348240eda	9
105171	cefadroxil 100 MG/ML Oral Suspension	SCD	27009a05-4d2b-4618-be76-39f348240eda	9
309048	cefadroxil 50 MG/ML Oral Suspension	SCD	27009a05-4d2b-4618-be76-39f348240eda	9
105171	cefadroxil (as cefadroxil monohydrate) 100 MG/ML Oral Suspension	SY	27009a05-4d2b-4618-be76-39f348240eda	9
309048	cefadroxil (as cefadroxil monohydrate) 50 MG/ML Oral Suspension	SY	27009a05-4d2b-4618-be76-39f348240eda	9
309048	cefadroxil 250 MG per 5 ML Powder for Oral Suspension	SY	27009a05-4d2b-4618-be76-39f348240eda	9
105171	cefadroxil 500 MG per 5 ML Powder for Oral Suspension	SY	27009a05-4d2b-4618-be76-39f348240eda	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68180-181-01	68180018101	50 mL in 1 BOTTLE (68180-181-01)	50 ml	2008-04-23	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefadroxil for Oral Suspension USP, 250 mg/5 mL and 500 mg/5 mL	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2025-10-08	HUMAN PRESCRIPTION DRUG LABEL	9